Cosmeceuticals Market to be Driven by Increased Desire of Consumers to Maintain Youthful Appearance

Developed economies with a high population are considered to be high-potential markets for cosmeceutical brands. People in the present generation are becoming conscious about their looks and thus are ready to spend extensively to maintain a youthful appearance by consuming or applying cosmeceutical products. The emergence of a well-heeled middle class bearing a taste for luxurious products in nations such as India, Brazil, China, and Russia is anticipated to boost the demand for cosmeceuticals throughout the forecast period.

On the basis of product type, the global cosmeceuticals market is divided into cosmetics and toiletries, tissue fillers, age-defying products, lip care products, hair care products, skin care products, and injectable cosmeceuticals. Among these products, anti-aging creams bear high potential in the near future. According to the chemical used in the product, this market is further classified into antioxidants, proteins, alpha hydroxy acids, botanicals, and enzymes. Among these, antioxidants are expected remain the strongest in this market in the coming years.

The research report on the global cosmeceuticals market is further segmented on the basis of geography into Asia Pacific, North America, Europe, and Rest of the World. The cosmeceuticals market is expected to witness steady but moderate growth in the developed nations of North America and Europe. On the flip side, the Asia Pacific cosmeceuticals market is expected to expand rapidly in the near future.

In developed European countries such as France, the United Kingdom, the Netherlands, Germany, and others, the obsession for looking young is one of the greatest growth drivers. The comparatively high per capita income in these nations allows the consumers to spend generously on cosmeceuticals. In addition, marketing activities carried out by several cosmeceutical companies are majorly concentrated in the U.S. and Europe. Cosmeceutical companies are majorly gaining traction in Asia Pacific, where the booming e-commerce industry has provided consumers with simple access to cosmeceutical brands across the globe. 

Get a PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=268

Furthermore, the research report talks about the competitive landscape of the global cosmeceuticals market, including the company profiles, business strategies, and recent developments in the industry. Some of the prominent players operating in the global cosmeceuticals market are BASF SE, Croda International, Colgate-Palmolive, Arch Chemicals, Unilever Group, Allergan Inc., and Procter & Gamble. Many other companies are expanding their horizons to enjoy competitive advantage in this market.

Future of Telemedicine - Key Trends and Forecast 2020

Telemedicine is the evolved format of traditional medicine that provides medical care to millions of individuals worldwide with the benefits of cost efficiency and convenience of location. The basic difference between traditional healthcare technology and telemedicine is the use of telecommunication technology to provide patients and medical practitioners the convenience of location, cost and time. With the advent of communication technology in medical sciences, telemedicine revolutionized the overall framework of healthcare. Patients were no longer subjected to travel or waiting periods and could seek medical attention at the comfort of their homes. This greatly changed the perception of medical practice, which is the major reason why telemedicine is currently considered synonymous with general medicine. Telemedicine involves the use of mobile communication technology and image/video transfer technology via the internet. The internet has provided the basis for information exchange, which is stored and maintained by the servers present at either hospitals or telemedicine service provider company at a nominal cost. 

Current Developments in the Global Telemedicine Market

At present, the global telemedicine technologies market is facing a number of challenges that it needs to overcome in order to ensure its high growth in the coming few years. Some of the major challenges hampering this market are the shortage of skilled and experienced professionals in remote areas and absence of consumer awareness about telemedicine technologies and their uses. Other major restraints suppressing the global telemedicine technologies market are the lack of proper insurance and strict regulatory framework governing this industry.

Currently, North America and Europe are leading the global telemedicine technologies market. This is due to the elevated acceptance of telemedicine technologies in these regions. In addition to this, the presence of enhanced healthcare and IT infrastructure promotes the adoption of telemedicine technologies.

Expected Developments in the Global Telemedicine Market

The global telemedicine technologies market is expected to grow at a double-digit CAGR during the forecast period of 2010 to 2017. In the coming few years, the improved access to patient care and telehealth technologies reaching new markets is expected to propel the market. Furthermore, with the advent of telemedicine technologies, the number of emergency room visits and hospitalization is expected to reduce drastically. Multiple healthcare providers can communicate with an individual episode of care and centralize all the existing data and streamline data collection via telemedicine technologies. This is expected to reduce the gap between clinician supply and patient demand.

According to market analysts, China, Brazil, India, and Russia will experience a high growth rate in the global telemedicine technologies market in the coming few years. These regions will benefit from their expanding populations and the accelerating incidence of chronic diseases such as asthma, diabetes, and heart failure. Furthermore, increasing healthcare costs and rising awareness of telemedicine in remote locations will also drive these markets.

Get a Sample Copy of the Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3032

Key players in the global telemedicine technologies market are thus focusing on the emerging markets of Russia and Brazil to expand their services. The global telemedicine technologies market is broadly segmented into software, hardware, and services. Some of the most prominent companies in the global telemedicine technologies market are AMD Telemedicine, McKesson Ltd., Philips Healthcare, GE Healthcare, and Cardio Net.

How Social Media and Big Data Aid Healthcare?

The rate of technological progression over the past few decades has been astounding, so much so that computing technology is finding it tough to keep up with Moore’s Law. Gordon E. Moore, in 1965, made a rough calculation that the number of transistors that a chip holds will double every two years, thanks to consistent demand for progressively advanced products. We are now at a point where standard silicon-technology-based chips are finding it tough to cram themselves with additional transistors. So while the advent of better forms of chip-making emerge, the point is clear that we’ve come a long way in a very short time. This only makes it logical that healthcare, one of the essential industries for mankind, uses what’s at the forefront of the technology of its generation. On top of the list for this generation is the barrage of social media data we put out into the world.

Get a PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5807

Tweeting for Better Health

In May 2011, researchers from the University of Iowa figured out a way to use Twitter to track diseases in terms of their level of reach and activity in the U.S. The studies were conducted during the influenza A H1N1 pandemic. The published report shows that the team of three scientists was able to successfully use Twitter to check the developments in public sentiment during the spread of swine flu. In addition to this, they also managed to measure the level of activity of the disease through tweets from different regions. The report conclusively showed that social media platforms, especially Twitter, can be easily used to track public concerns over health and thus gauge the spread of diseases.

And the Twitter train doesn’t stop at contagious diseases and pandemics, either. In early 2015, University of Pennsylvania researchers stated that they can correlate region-based data on heart disease to a higher rate of negative Tweets. The researchers compared the data published by the CDC and the general emotional quotient of tweets from various regions. They found that there was a direct proportion between the number of emotionally negative tweets and the prevalence of coronary heart diseases. Of course, we need to remember that correlation does not imply causation – just because one sends negative Tweets does not mean they have heart disease. But it is data like this that can lead to a more concrete analysis for a better healthcare structure.

Big Data and Predictive Healthcare

The global healthcare industry is taking its next big step already: healthcare is on its way to becoming more proactive than reactive. What this means is the incorporation of intuitive technology that will anticipate patient problems before they happen, based on previously collected data. While this could practically spell out miracles for patients, we are still a long way from creating the perfect predictive healthcare system. But as a starting point, we have the currently trending big data business.

Big data can work better with healthcare to make it more intuitive. For instance, the piles of data gathered from one person regarding his/her eating habits, workout routines or lack of exercise, and sleeping habits, can be vital in telling whether that person is susceptible to diseases or not. With big data analytics, this can be performed efficiently for a large population. The health records can even span across generations of a family, enabling medical knowledge of genetic traits that might show up in new generations.

There are many other tech trends that can be extremely helpful in the field of medicine; many of them already are: improved sensory tech and better materials are being used in performing delicate surgeries and creating state-of-the-art prosthetics. Doctors all over the world are making the most out of the Internet and high-speed data transmission to create live global lecture halls where veterans perform surgeries in their OR while the others watch on their screens and learn. Indeed, we have come a long way from non-sterilized amputations and witch doctors, and into concepts that, ironically, seem more and more like magic.

Medical Devices Outsourcing Market to Expand at 11.6% CAGR till 2018 owing to Increasing Demand for Quality Healthcare Services

Medical devices outsourcing refers to the process of medical device manufacturers hiring third-party members for the completion of business-related functions such as product designing, upgrading, maintenance, and testing. Outsourcing such activities allows medical device manufacturers to focus solely on its core competencies and leave the rest to third party professionals. 

Leading manufacturers in the medical device industry are opting for outsourcing solutions to not only manage their device manufacturing processes but also to cut costs and use saved resources for technical and clinical innovations. Medical devices outsourcing has emerged as a practical and cost-effective solution in various disciplines of medicine including orthopedics, cardiovascular, anesthesiology, radiology, and neurology. 

Product Outsourcing a Rising Trend in Recent Times 

According to a report published by Transparency Market Research, the global medical devices outsourcing market is projected to develop at a CAGR of 11.6% from 2012 to 2018, rising from a value of US$21.1 billion in 2012 to US$40.8 billion by 2018. 

This growth in the medical devices outsourcing market can be attributed to the growing demand for quality healthcare services and significant developments in the field of medical technology. Looking to cut costs and attain sustainability in the long run, more and more players are opting to outsource parallel operations to smaller and more specialized service providers. Functions that were once performed by in-house teams within healthcare companies are now being taken care of by external sources on a project-based routine.  

Product Design Services Most Highly Outsourced Medical Device Service  

On the basis of application, the medical devices outsourcing market is categorized into Class I, Class II, and Class III medical devices. Of these, Class II devices held the largest share of the overall market owing to moderate related risks and limited regulatory requirements. On the basis of service, medical device outsourcing includes product implementation services, product design and development services, product upgrade services, regulatory consulting services, product maintenance services, and product testing services. Rising challenges in manufacturing as well as technical cost containment have made product design services the most frequently outsourced service. This segment held a share of 29% in 2012, making it the largest service segment of the medical devices outsourcing market. 

Driven by Rising Healthcare Costs, North America Emerges Leader in Medical Devices Outsourcing Market  

The global medical devices outsourcing market comprises four main regions: North America, Europe, Asia Pacifica, and Rest of the World. Surging healthcare costs have enabled North America to emerge as the leading regional market for medical devices outsourcing. In addition, increasing number of medical insurance providers and their expanding coverage in the region has resulted in the growing demand for quality healthcare services, thereby forcing industry players to resort to medical devices outsourcing. Asia Pacific, on the other hand, has been identified as an immensely lucrative market for medical devices outsourcing given the region’s recent potential to attract foreign investors. 

The prominent players functioning in the global medical devices outsourcing market include Micro Systems Engineering GmbH, Accellent Inc., Cirtec Medical Systems LLC., Active Implants Corporation, Avail Medical Product, Creganna-Tactx Medical, and Mdmi Technologies Inc. 

For complimentary access to more information on this research, please visit: http://www.transparencymarketresearch.com/medical-devices-outsourcing-market.html

Nanoclay Reinforcement Market will Continue to Grow Strongly Through 2023

Application of organo-modified montmorillonite (MMT), also known as “Nanoclay,” in the reinforcement of polymer-based composites has managed to attract a lot of attention from the industrial sectors. Addition of tiny amounts of nanoclay significantly augments the mechanical properties of pristine polymers. Nanoclay reinforcements are utilized in various applications for the enhancement of mechanical, thermal, and electrical properties. This includes hybrid phenolic friction composites, medium density fiberboard (MDF), liquid silicone rubber, fibers, polymer films, nonwovens, and other composite materials. MDF is wood-based composite used primarily in the furniture industry. Nanoclay reinforcement has found an extensive application base across various industries including adhesives, cable inks, coatings, pharmaceuticals, and automotives.

Nanoclay reinforcements is anticipated to grow into one of the most attractive segments in the nanotechnology market due to low manufacturing cost and ready availability of raw materials. The global nanoclay reinforcements market is anticipated to witness steady growth during the next few years due to rising demand for reinforced plastics in automobiles, aerospace, electronics, and construction industries. The nanoclay reinforcement market has expanded significantly during the past few years due to rising demand across companies manufacturing plastics. This trend is likely to continue during the forecast period. Rapid growth of these end-use industries is anticipated to further augment the nanoclay reinforcement market.

Request a Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5219

Production of MDF has been on a rise during the past few years owing to rapid growth of the furniture industry in Asia Pacific. This trend is estimated to boost the nanoclay reinforcement market during the next few years. Application of nanoclay reinforcement in liquid silicone rubber (LSR) is expected to witness strong growth during the next few years due to increasing demand for nanoclay-reinforced LSR in electrical, medical, automotive, and aerospace industries. Growth in application of nanoclay in reinforcement of polymer films, nonwovens, and fibers (including nylon 6, injection-molded polypropylene, and melt spun fiber) is projected to be one of the factors driving the market during the next few years.

North America has been the strongest market for nanoclay reinforcement in the past few years, followed by Europe and Asia Pacific. Increase in research and development activities related to nanomaterial and its technologies by major market players, which are supported by governmental initiatives, has proved to be a critical market driver in North American. Europe and Asia Pacific are anticipated to witness significant growth during the next few years due to rising demand for nanoclay reinforcement in end-use industries. Additionally, technological advancement along with increasing investment in nanotechnology research activities is expected to augment market growth in the near future. Development of bio-based nanoclay reinforcements such as soy-based unsaturated polyesters is likely to offer new opportunities for market growth during the next few years. Soy-based unsaturated polyester reinforcements exhibit much higher efficiencies.

Some of the major players in the nanoclay reinforcement market include Southern Clay Products Inc., Nanocor Inc., RTP Company, Crystal Nanoclay Pvt. Ltd., NanoClay and Technologies Inc, Nanoshel LLC among others.

Browse Report: http://www.transparencymarketresearch.com/nanoclay-reinforcement-market.html

Neural Stem & Progenitor Cell Products Market to Grab the Largest Market Share by 2019

Neurogenesis is a mechanism through which neurons are generated through neural stem cells or progenitor cells. Neurogenesis is active during pre natal development and is responsible for populating the brain with neurons. This significant process of neuron generation takes place in two parts of the brain namely subventricular zone and hippocampus. The rate of neurogenesis mechanism is mainly influenced by hormones such as testosterone. Neural stem cells are multipotent self renewing cells that are capable of generating phenotypes of the nervous system. These cells include astrocytes, oligodendrocytes and neurons. While, neural progenitor cells are the lines of stem cell division that usually undergo limited number of stem cell division invivo. Neural stem cells have been promising approach for the treatment of nervous system disorders. 

Factors such as increase in geriatric population, investment in R&D and improved understanding of the nature of neurologic diseases are driving the neural stem and progenitor cell products market growth globally. Since, aged population is more prone to brain disorders therefore; increase in geriatric population will likely increase the neural stem and progenitor cell products market worldwide. Additionally, as per the World Health Organization, by 2020 nearly 14.1% of the world population will suffer from neurologic disorders which would further lure manufacturers for the production of neural stem and progenitor cell products. Also as per the estimates approximately 5.4 million Americans were diagnosed with Alzheimer’s in 2012. Of these nearly one in eight people aged 65 years and above has Alzheimer’s disease. Additionally, 4% are under age 65, 44% are between age 75 to 84 and 46% are 85 years or older are diagnosed with Alzheimer’s. Hence, collectively all of the mentioned factors would increase the demand for neural stem cell products. 

The market for neural stem and progenitor stem cells can be categorized on the basis of applications and end users. Neurotoxicity testing, neural tissue engineering, personalized medicines, cellular therapies for the treatment of central nervous system conditions and drug target validation and testing and others are some of the major applications of the neural stem and progenitor cell products market. Academic labs, commercial labs, private labs and government laboratories are some of the major customers of the market. Development of neural stem cells products by the pharmaceutical sector represents a significant opportunity as development of new drugs is costly and bringing new drugs into the market is highly unpredictable.  

Some of the key players in the neural stem and progenitor cell products market are Stem Cells Technologies, EMD Millipore, Life Technologies Corporation, Thermo Fisher Scientific, Neural Stem, BD Biosciences, Lonza, NeuroGeneration, AlphaGenix, Inc. SA Biosciences, R&D Systems and others. Some of these manufacturers offer array of products for neural stem cell culture, media, supplements, growth factors and substrates. 

Increasing Research-driven Medical Treatment Practices Propelling Global Cell Culture Market

Cell culture is a process wherein eukaryotic or prokaryotic cells are produced outside their natural environment, in controlled laboratory conditions. Heavy research involved in developing the optimum environment for cells to survive in artificial surroundings has led cell culture to emerge as one of the key tools in cellular and molecular biology, carcinogenesis, and mutagenesis studies. Owing to this, the global cell culture market is poised to be worth US$11.3 bn by 2022, increasing from its 2013 valuation of US$6.1 bn at a CAGR of 7.10% therein.

Growing Medical Research for Treatment of Multiple Diseases Benefits Global Market

The medical research sector exhibits an exclusive demand for cell cultures, wherein studies pertaining to aging and metabolic cell processes, origination of mutations, and effect of new drugs on cells are some of the major research areas that are benefitting the cell culture market. Cancer detection, manufacture of biologics, and drug discovery are some of the other medical research areas that are triggering growth of this market. 

R&D initiatives taken by life sciences and biotechnology companies, and academic and industry collaborations for the advancement of cell culture apparatus and methodologies have been significantly favorable for the growth of the cell culture market. The use of cell and tissue cultures to study the cellular mechanisms and drug response for diseases such as Parkinson’s and Alzheimer’s has been notable for the development of the cell culture market.

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Ethical Reasons Favor Cell Culture Methodologies sans Animal Components

The global cell culture market is divided on the basis of product type into two major segments, cell culture instruments and cell culture consumables. Cell culture consumables comprise the sera, media, and reagent segments. Out of these, it is the cell culture media segment that will be the fastest growing. The growing preference for animal-derived-component-free (ADCF) media, which ensures compliance with the ethical standards of medical research, is attributed to the phenomenal rise of this market segment.

By instrument, culture systems, pipetting systems, biosafety cabinets, incubators, roller bottle equipment, cryostorage equipment, and others are the segments of the cell culture market. Technological advancement in the design and function of cell culture instruments and increasing adoption of automated culture systems by manufacturers and researchers are promoting growth of the instruments product segment of the market. 

Outsourcing Practices Benefit Asia Pacific Cell Culture Market 

Apart from this, the global market for cell culture is divided into the regional segments of North America, Asia Pacific, Rest of the World (RoW), Europe, and Latin America. In 2013, North America stood as the largest regional market for cell cultures. Consistent research initiatives, which involve huge investments for the development of biologics and drugs, and the presence of top-notch biotechnology, pharmaceutical, and food and beverages companies are propelling the cell culture market in the region.

Asia Pacific is expected to be the fastest growing market for cell culture in the near future. Economic growth in China and India, in particular, has led to the development of modern research and manufacturing facilities, which is encouraging contract-based manufacturing and contract-based research outsourcing practices from the West.

In the Rest of the World and Latin America regions, increasing investments from both public and private agencies for life sciences research is driving the cell culture market. Improving healthcare infrastructure and governmental support for modern research practices are further aiding the growth of this market. 

Browse Full Global Cell Culture Market Report With Complete TOC @ http://www.transparencymarketresearch.com/cell-culture-market.html

Introduction of Cost-effective Video Telemedicine Technologies the Way Forward in Emerging Countries

Video telemedicine refers to a group of technologies and devices used to enable interaction between patients in remote areas and medical professionals. According to a recent UN survey, close to 50% of the global population still resides in rural areas. In spite of the rapid pace of urbanization in most developing countries around the world, a significant chunk of the global population is still devoid of qualified medical attention. This calls for an effective solution to enable access to healthcare to this populace, which has led to the rapid emergence of the telemedicine sector, and the global video telemedicine market in particular, in recent years.

According to a market analysis report recently published by leading market intelligence firm Transparency Market Research (TMR), the global video telemedicine market was worth just under US$560 mn in 2013. However, boosted by the urgent need for effective healthcare in rural areas, the market is expected to almost triple in size by 2020; TMR analysts predict that the video telemedicine market will expand to US$1.6 bn by 2020 at a CAGR of 16.50% therein.

Request a Sample Report: http://www.transparencymarketresearch.com/v-telemedicine-market.html

Improved Streamlining of Healthcare Dispensation Boosts Video Telemedicine Market

The major advantage offered by video telemedicine technologies is the increase in efficiency brought about in management of diseases. Since physically visiting a doctor can be taxing or in some cases impossible for rural patients, video telemedicine allows doctors to prescribe medication or therapies through a diagnosis over video conferencing. Apart from patients in remote areas, urban patient-doctor interactions are also benefited by video telemedicine; support for the same from insurance companies is also growing, promoting the acceptance of video telemedicine.

Apart from doctor-patient interactions, video telemedicine also comprises interactions between hospitals. Due to the ease of teleconferencing, video telemedicine allows for much easier and faster transfer of information than with conventional media. This allows top medical institutes to collaborate on medical research of various kinds, boosting the overall healthcare scenario.

Emerging Regions Promising for Global Video Telemedicine Market

Even though, at first glance, video telemedicine is most helpful in emerging regions, due to the relatively lower spread of urbanization, it is in regions such as North America and Europe that the video telemedicine market has the strongest growth prospects. The availability of high-tech medical infrastructure in North American and Western European countries has so far allowed video telemedicine to become a major healthcare technology. The North America market for video telemedicine, which led the global market in 2013, is expected to exhibit a stellar 15% CAGR from 2014 to 2020.

On the other hand, the lack of skilled personnel, advanced medical infrastructure, and significant government funding has restrained the video telemedicine market in regions such as Asia Pacific, Latin America, and Africa. Innovation of cost-effective video telemedicine technologies will help the market post strong figures in these regions. The growing support from APAC and Latin American governments for upgradation of nationalized healthcare infrastructure will also help the market for video telemedicine massively, as the increasing availability of high-speed mobile data in these regions is making availing video telemedicine easier than ever. Accordingly, the market for video telemedicine accessed through 4G technology is expected to expand the fastest in the aforementioned forecast period, with an 18% CAGR expected for the segment.

Browse Full Global Video Telemedicine Market Report With Complete TOC @ http://www.transparencymarketresearch.com/v-telemedicine-market.html

Future of U.S. Population Health Management Solutions

Population health management, or PHM, refers to the collection of overall data pertaining to patients from various health information technology resources. This data is then analyzed and collated into a patient record that is used for deciding the actions that care givers and governments should take to improve the overall quality of life. This meticulous service has garnered massive attention in recent years, especially in the U.S.

Market analysts, who had valued the U.S. population health management solutions market in the US$3.4 bn in 2014, are now expecting it to reach US$45.7 bn by 2023, at a CAGR of 23.9% from 2015 to 2023. The unique ability of population health management solutions to deliver promising outcomes at a lower cost will become the undercurrent for this remarkable growth.

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7412

Population Health Management: An Essential Tool for Health Management

Population health management solutions group the patients depending on their health conditions, risk factors, health status, and so on for minimizing untimely and expensive medical interventions involving emergency surgeries, long period of hospitalizations, and tough invasive procedures and tests.

The U.S. population health management solutions market is segmented on the basis of source, mode of operation, and end users. The sources, based on which this market is segmented, are software and service. By mode of operation, the market features the following segments: web-based, cloud-based, and premise-based. Furthermore, the end users of population health management solutions in the U.S. are government insurance providers, health care providers, private insurance providers, pharmaceutical companies, medical device organizations, and others such as diagnostic and imaging centers, employers, and research institutes.

Cloud-based Population Health Management Systems Segment to Drive Market’s Growth

Cloud-based population health management systems are expected to spearhead the U.S. population health management solutions market due to the integration of information technology in the healthcare sector. Furthermore, the population health management solutions services segment will also witness an upward trend in the coming years. However, the population health management solutions services segment will be led by the cloud-based population health management systems segment in the next few years.

Adoption of Healthcare IT Leads to Progress of Cloud-based Population Health Management Systems 

Cloud-based population health management systems will dominate the U.S. population health management solutions market due to the adoption of healthcare IT, springing pharmaceutical industry, and health insurance companies. This demand will also be fueled by a huge need for health management solutions across the U.S. The continuous help of these solutions to resolve the pressure on the U.S. health systems is also driving their adoption rate. Additionally, population health management tools also help in the management of vast databases to monitor and compare the overall clinical and financial results of population groups that are being studied.

Some of the important players in the U.S. population health management solutions market are Verisk Health, Conifer Health Solutions, Caradigm, NextGen Healthcare Information Systems, LLC, Health Catalyst, Healthagen LLC, International Business Machines (IBM) Corporation, Lumeris, Persivia, Premier, Inc., OptumHealth, Inc., The Advisory Board Company, ZeOmega, Inc, and Wellcentive, Inc. Most of these companies are constantly striving to devise innovative solutions to maintain a leading position in the highly competitive U.S. population health management solutions market.

Browse More: http://www.transparencymarketresearch.com/us-population-health-management-solutions-market.html

Appeal of Young Look among Baby Boomers Drives Anti-aging Market

Baby boomers advancing towards retirement are determined to defy the aging process. Every year, they spend millions of dollars on face-lifts, wrinkle creams, and workout regimens in pursuit of their ‘forever young’ mindset, which cosmetic product manufacturers, cosmetic surgeons, and entrepreneurs are eager to capitalize on. Baby boomers constitute a 70-million-strong group for legions of businesses to target.

The Boomers, who grew up in America’s postwar prosperity, are regarded as a more privileged generation than any before them. From top-of-the-line incomes to widespread government subsidies for post-war education and housing, they were the wealthiest and the most physically fit generation. 

Browse Research Report: http://www.transparencymarketresearch.com/anti-aging-market.html

Nevertheless, often criticized for rejection of traditional values and their characterization of excessive consumerism, the boomers were a disparate lot.  The demographic group that embraced fashion in every department, self-care and looks being foremost to keep with their modernist mindset.

Health Issues and Aging Now upon Baby Boomers 

With baby boomers already in their 60s, aging and health problems have already struck upon individuals of the age group. Their impending retirement from the workforce has also weighed heavy on this demographic. Nonetheless, in true baby boomer style, this group will probably approach the state in a new way. Regardless of aging, baby boomers are emphatic upon staying in their homes and communities and not in assisted-living settings, which necessitates the usage of anti-aging products and services. 

Hence, the desire of the baby boomer generation to retain their youth is expected to be a major revenue generation channel for the anti-aging market in the coming years. As a result, the anti-aging market, which amounted to a value of US$122.3 bn in 2013, is slated to shoot up to US$191.7 bn by 2019, says a recent market study by Transparency Market Research (TMR).

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/anti-aging-market.htm

TMR analysts have presented the views of the vendors of anti-aging products and the medical community about the use of anti-aging products and services:

1) Anti-aging enthusiasts assert that the use of recognized deficit-correcting treatments and oral supplements helps in the near term as well as long run with increased life expectancy. On the contrary, critics as well as the most of the medical fraternity contend that anti-aging interventions do not give desired results and may also be harmful. 

2) Mainstream organizations such as the National Institute on Aging advise consumers to be wary about possible scams due to false promises labeled on anti-aging products. Rather, the institute contends aging to be normal, which cannot be slowed or reversed with the use of pills or treatments that claim to lead to endless youth.

3) North America is the dominant market for anti-aging products and services due to a large concentration of the baby boomer population. Baby boomers constitute 44% of the U.S. population and account for 70% of the disposable income in the country, thereby accounting for a large total expenditure on aesthetics enhancing and anti-aging products.

Ostomy Drainage Bags Market to Report Modest Yet Steady CAGR of 4.7% as Patients' Awareness Levels Rise

An ostomy drainage bag plays a crucial role in the collection of the waste excreted by a patient. The use of this prosthetic medical device is necessitated after an ostomy – a procedure that entails the diversion of waste from the natural biological system (such as the bladder, colon and ileum) to an artificially created stoma within the abdomen. The global ostomy drainage bags market has shown steady expansion in recent years, thanks in part to a rapid growth in the number of ostomy procedures conducted globally. The reported increase in ostomy procedures is a result of the rising incidence of diseases such as bladder cancer, colorectal cancer, inflammatory bowel disease and Crohn’s disease. According to market research analysts, the global ostomy drainage bags market will report a CAGR of 4.7% between 2014 and 2022, by which year it would be worth US$2,759.5 million.

Initiatives to Clear Misconceptions about Ostomy Augur Well for Ostomy Drainage Bags Market

There are several factors that have supported the growth of the global ostomy drainage bags market. For one, a greater degree of awareness that has been created via initiatives such as the World Ostomy Day (observed every year on October 6 worldwide) has helped increase the adoption of ostomy drainage bags. Moreover, a number of institutions in the healthcare industry have taken active measures to help patients clear misconceptions associated with ostomy as well as the use of ostomy bags. With the alleviation of the stigma associated with ostomy drainage bags, there has been a gradual yet steady increase in the demand for them.

However, these initiatives need to be implemented in several other emerging and developing markets where awareness levels still remain dismal. If companies and healthcare organizations are able to encourage awareness in emerging markets, the scope for growth will expand as well.

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=325

Colostomy Bags are Most Commonly-Used Product in the Global Ostomy Drainage Bags Market 

There are several key product types within the global ostomy drainage bags market. These include: Colostomy bags, urostomy bags, and ileostomy bags. As of 2013, colostomy bags were seen to be the most dominant segment within the global ostomy drainage bags market. This can be ascribed to the high occurrence of colorectal cancer worldwide. Moreover, a greater degree of awareness pertaining to colostomy now exists – this consequently leads to more colostomy bags being used after the procedure.

In emerging countries in the Latin America and Asia Pacific region, market players offer a number of purchase and pricing options for colostomy bags. This has proven favorable for the growth of the overall ostomy drainage bags market. In the backdrop of these asspects, the ostomy drainage bags segment will see the fastest rate of growth between 2014 and 2022, states a recent market research report.

Market Analysts Observe Higher Demand for Multi-use ostomy Drainage Bags

The ostomy drainage bags market offers single-use as well as multi-use bags. Of these, the market for multi-use ostomy drainage bags was reported to be larger in 2013. The demand for multi-use ostomy drainage bags is higher because they are the product of choice in surgical procedures such as urostomy and ileostomy.
The key advantage of the multi-use ostomy drainage bag is that it can be irrigated and re-used to help patients save costs without compromising on their hygiene and safety. This also gives a multi-use ostomy drainage bag an advantage of its single-use counterpart. The trend is especially relevant to markets such as Asia Pacific and Africa where consumers are conscious of cost.

Browse Full Report at http://www.transparencymarketresearch.com/ostomy-drainage-bags-market.html

Global Cell Culture Market to Reach US$11.3 bn by 2022 due to Rising Demand in Stem Cell, Cancer Research

Cell culturing is a process through which cells are grown away from their natural environment in controlled laboratory conditions. Cell cultures help in carcinogenesis and mutagenesis studies and for studying the biochemistry and physiology of cells, the effect of biomolecules and drugs on cells, and is used in cellular and molecular biology. Cell culture provides reproducibility and consistency of results that is achieved by the usage of a batch of clonal cells. Research into various diseases such as Alzheimer’s, Parkinson’s, and diabetes uses cell culture to study cellular mechanisms.

The global cell culture market is expected to reach a value of US$11.3 billion by 2022, growing at a CAGR of 7.1% from 2014. Globally, the cell culture market is experiencing tremendous growth due to the demand for biopharmaceutical products. The cell culture market is expanding due to the amplified biologic drugs market and related uses in vaccines, proteins, and antibodies. Stem cell therapy is used for treating a variety of diseases and increase in stem cell research is directly boosting the cell culture market.

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Advent of New Research Technologies and Increased Investment Boost Cell Culture Market 

Government initiatives for improvement of healthcare infrastructure and investment in research are the prime reasons for the augmentation of the global cell culture market. Private and public investment in biological products is also a major factor responsible for boosting the cell culture market. The global cell culture market is expanding and providing great market opportunities due to progression in cell culture technologies such as 3D cell culturing by magnetic levitation, nano-particle facilitated magnetic levitation, and recombinant DNA.

Cell cultures are used for biological manufacturing, cancer research, gene therapy, stem cell research, IVF technology, diagnosing diseases, and for drug screening and monitoring. Investments by life science organizations and collaborations between industries and academic centers are propelling the global cell culture market.

Cell Culture Media Expected to Grow Fastest

The segmentation of the cell culture market by product type breaks down the market into two categories: instruments and consumables, which are sub-segmented into reagents, media and sera. Cell culture media are the most rapidly growing segment owing to them being animal-derived component free (ADCF). The instruments segment is broken down into the sub-segments of cryostorage equipment, roller bottle equipment, incubators, pipetting instruments, and culture systems. Technological innovations and demand for automated culture is driving the demand for this segment.

In North America, large-scale drug development and the presence of major companies dealing in biotechnology, pharmaceuticals, and food and beverages made the region the largest regional cell culture market in 2013; Europe follows North America in the market hierarchy. Asia Pacific is anticipated to grow rapidly as a regional cell culture market due to economic improvement in countries such as India, China, Japan, and Australia. Rest of the World (RoW) and Latin America are also expected to grow substantially owing to augmented investment by private and public institutions in life science research.

Key players in the global cell culture market include BD Biosciences, EMD Millipore, Thermo Fisher Scientific, Corning Incorporated, Sigma-Aldrich Corporation, Inc., GE Healthcare, VWR International, PromoCell GmbH, and. Lonza Biosciences.

Browse Full Global Cell Culture Market  Report With Complete TOC @ http://www.transparencymarketresearch.com/cell-culture-market.html

Small Animal Imaging Market: Extensive Application of Preclinical Imaging Modalities at Clinical Research Organizations Will Push Market At 8.6% CAGR during 2014-2020

Small animal imaging technology has marked itself as the most useful tool in preclinical research globally. The technology has proved to be of great importance in developmental biology studies and drug development research programs. Being non-invasive, longitudinal studies are possible with accurate and detailed analysis. The global small animal imaging market has been studied from three main perspectives: by devices, by reagents, and by application areas. The devices in the preclinical imaging market include micro-computed tomography (CT), micro-magnetic resonance imaging (MRI), micro-positron emission tomography (PET) and micro-single positron emission computed tomography (SPECT), multimodal imaging, optical imaging, micro-ultrasound imaging and micro-photoacoustic tomography (PAT). The contrast reagents market has been studied for CT, MRI, nuclear imaging, optical imaging and ultrasound imaging technologies.

Although small animal imaging has been extensively used in various research areas, the market for

key application segments has been estimated. These segments include oncology, cardiology, autoimmune, neurology and psychiatry, and other applications. A detailed market analysis and forecast for each of these segments have been provided in this study in terms of market revenue (USD million) for the period 2012 to 2020. The report also provides the compounded annual growth rate (CAGR %) for each of these segments for the forecast period from 2014 to 2020, considering 2012 and 2013 as base years. Furthermore, the global small animal imaging market has also been divided according to major geographies: North America, Europe, Asia Pacific and Rest of the World.

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2469

Global Small Animal Imaging Market – Regional Analysis, Prevailing Trends, and Restraints

Regionally, the global small animal imaging market is led by Europe and North America due to factors like high rate of adoption of expensive devices, frequent product launches, and greater activities with regard to preclinical research. The rapidly growing markets in the global small animal imaging market are the Asia Pacific and Rest of the World. These two regions are primarily driven by greater industry based funding for carrying out pharmaceutical based preclinical research, and increasing number of CROs.

The growth and performance of the global small animal imaging market can be attributed to higher research funding activities, and greater technological advancements. There has been a surge in the demand for reagents because of increasing number of reagent manufacturers, frequent purchase, and high shelf life of the devices.

Most of the companies operating in the global small animal imaging market are focusing greatly on improving multimodal imaging devices that are MRI based, like MRI and PET devices. This trend is expected to drive the global small animal imaging market by way of greater growth opportunities in the years to come. The main growth inhibitors in the global small animal imaging market are limited access to nuclear imaging reagents, and slow rate of adoption propelled by steep development costs.

Some of the prominent players operating in the global small animal imaging market are Targeson, Inc., SCANCO Medical AG, Siemens AG, Promega Corporation, Perkin Elmer, Inc., Miltenyi Biotec GmbH, FujiFilm VisualSonics, Inc., LI-COR Biosciences, Inc., TriFoil Imaging, Inc., Bruker Corporation, Aspect Imaging, and Agilent Technologies, Inc.

Browse Report: http://www.transparencymarketresearch.com/small-animal-imaging.html

Future of Pharmacovigilance Market

According to the World Health Organization (WHO), pharmacovigilance is an activity aimed at promoting safe management and administration of drugs. Severe government regulations, drug inspection rules, and the patient’s need to immediately report illnesses have propelled the global pharmacovigilance market. Innovations in medical products that promote faster and more accurate treatment of various diseases will enable rapid development of the global pharmacovigilance market during the forecast period.

Intensifying regulatory expectations, tougher inspection system, and instant need for patient reporting boost

the adoption rate of pharmacovigilance among pharmaceutical companies. Rise in the prevalence of

acute and chronic diseases has consequently led to an increase in the incidences of drug consumption, thus leading to growth in the number of adverse drug events and drug toxicity cases. Furthermore, safety regulations, risk of high-profile safety issues, large volume of post-market events to be reviewed along with negative media coverage have bound the pharmaceutical players to take support of various outsourcing services for drug monitoring. Two major outsourcing providers preferred by pharmaceutical manufacturers for pharmacovigilance services are namely, traditional CROs (e.g. Covance, Inc., Quintiles Transnational, INC Research, etc.) and BPOs (e.g. Capgemini, Cognizant, Infosys Ltd., Tata Consultancy Services Limited, etc.). Outsourcing services do not only help in cost saving, but also support process efficiency. Pharmaceutical companies are now entering into long-term partnerships/service agreements with CROs and BPOs to reduce the pharmacovigilance process related expenditure, incurred right from drug discovery to post-marketing approvals.

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1729

In addition, pharmacovigilance requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting due to which pharmaceutical companies are opting for outsourced pharmacovigilance services in order to reduce the burden of clerical functions as well as capital expenditures.

Pharmacovigilance is a key component of an effective drug regulation system for monitoring and evaluating adverse drug reactions (ADRs). Pharmacovigilance activities are an important part of clinical research and are growing at a significant pace. At present, the global network of pharmacovigilance centers, harmonized by Uppsala Monitoring Centre, are operating on the global level for appropriate functioning of the process of drug safety monitoring across the world. Large volume of international ADR reports collected in a central database would serve as a contributing factor to the effort of national drug regulatory authorities, thus improving the safety profile of drugs that would help avoid drug related disasters.

However, the pharmacovigilance market is facing several hurdles and challenges to develop a better health care system. Challenges that are acting as major restraining factors for pharmacovigilance market are web-based drug information and sales, perceptions to harm and benefit, high risk associated with data security and unavailability of skilled professionals.

Browse Report: Pharmacovigilance  Market

Key Factors Fuelling Medical Waste Management Market

Every year a substantial amount of medical waste is generated around the world owing to the overall growth of the healthcare industry and increasing geriatric population. Medical waste is primarily generated in healthcare settings such as nursing homes and hospitals, physician’s chambers, diagnostic laboratories, veterinary centers, and pharmaceutical companies. The waste generated from these healthcare sectors can be categorized in four major segments, namely hazardous, infectious, radioactive, and general waste.

Continuously expanding healthcare industry supported by growing population with geriatric population in particular has led to the generation of substantial amount of medical waste, each year, over the world. These medical wastes have been categorized into four major types, namely, infectious, hazardous, radioactive and general wastes. Of these infectious, hazardous and radioactive medical wastes being potentially risky to human as well as environment are required to be disposed of with special caution. General wastes which are similar to common domestic and official wastes and do not require special treatment. There are a large number of companies that offer waste management services to healthcare facilities seeking help for medical waste disposal. The medical waste management market was valued at USD 14,541.5 million in 2012 and is expected to reach USD 20,130.1 million in 2019, growing at a CAGR of 4.8% during the forecast period 2013 to 2019.

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2268

Almost 80% of the medical waste generated every year consists of plastics, papers, and other materials that are quite similar to general household or office waste. But the remaining 20%-25% consists of bioactive waste materials such as used syringes, blood-soaked bandages, cultures, stocks, unused or expired medicines, and many more, which are harmful to both humans and the environment alike. Such waste products need to be disposed of properly. Poor handling of these wastes has the potential of exposing patients, waste handlers, and healthcare professionals to serious infections.

Geographically, North America held the majority share of the overall medical waste management market, followed by Europe that accounted for the second largest share. These two regions are expected to retain their position throughout the forecast period 2013 to 2019. Governmental regulations mandating proper disposal of medical waste across North American and European countries has been considered as one of the major factors driving market growth in these regions during the forecast period. In Asia-Pacific region, Japan, Australia and New Zealand are the major markets that offer immense opportunities to waste management companies operating in this market. However, in countries like India and China, the market is highly untapped owing to low awareness level and due to lack of strict governmental regulations. In Rest of the World (RoW), Brazil, Mexico, South Africa, Israel, Turkey and UAE are the major markets where medical waste management market is expected to record maximum growth.

Great Expert Research Report: http://www.transparencymarketresearch.com/medical-waste-management-market.html

Stericycle, Inc., Waste Management, Inc., Republic Services, Inc., Veolia Environmental Services, Suez Environment SA, Clean Harbors, Inc. and US Ecology, Inc. are some major companies providing various waste management services to healthcare facilities seeking help for waste disposal.

Hospital Acquired Disease Testing Market to Benefit from Increasing Infection-related Hospitalization, to Expand at 19.3% CAGR by 2019

The market study offers an extensive analysis of the global hospital acquired disease testing market, which includes a comparative analysis of the past and present behavior of this market. The report also examines the growth prospects of this market in the coming years.The report states that the increasing prevalence of healthcare associated infections (HAIs) and resistance to drugs of an increasing number of pathogens are the primary factors driving the hospital acquired disease testing market. 

In addition, the implementation of prevention codes by several governments around the world to keep a check on HAIs is furthering the growth of this market. Stringent regulations in place combined with expiration of PCR (pre-hospital care report) patents will aid growth of the hospital acquired disease testing market.However, the report states that in developing economies, inadequate funds, lack of skilled labor, and insufficient quality control mandates slow down the growth of this market.

The global market for hospital acquired disease testing is divided on the basis of infection types and geography. By infection type, the market is segmented into urinary tract infection (UTI) testing, pneumonia testing, methicillin-resistant staphylococcus aureus (MRSA) testing, surgical site infection (SSI) testing, blood stream infection (BSI) testing, and others (GI, respiratory, bone, cardiovascular, etc.).By geography, the global hospital acquired disease testing market is spread across North America, Asia Pacific, Europe, and Rest of the World.By infection type, currently, the urinary tract infection testing segment leads the market and is expected to rise at an 18.1% CAGR for the forecast period. As such, the UTI segment will be valued at US$2.1 bn by 2019.

However, the SSI testing and pneumonia testing segments will also exhibit high demand from developing countries in Asia Pacific in the next few years. In this region, the growth of the hospital acquired disease testing market has been beneficial for progressive clinical research into the behavior of various pathogens. The increasing demand for reduced healthcare costs from both healthcare institutions and patients has been aiding growth of the hospital acquired disease testing market and its allied markets as well. 

Microbiology Culture Market to exceed US$7.59 bn by 2023, Bacterial Culture Media to Lead Growth

The microbiology culture market has grown significantly in the last few decades in terms of demand in various end-user industries. Academia, clinical research organizations, and commercial end-user industries such as pharmaceutical, cosmetics, and food and beverage are providing impetus to the global microbiology culture market. The increasing potential of bioprocessing and biopharmaceutical applications has driven demand for microbiology culture media products.

The microbiology culture media market is witnessing strong growth due to factors such as increasing food concerns worldwide, rising number of food product recalls, and growing impact of press coverage on food processing industries. The bacterial culture media segment accounted for the larger share of the global microbiology culture market in 2014. Moreover, the segment is likely to continue its dominance during the forecast period from 2015 to 2023 due to expected rise in application in food microbiology, pharmaceutical microbiology, and disease research. In terms of culture media, the complex media segment held the largest share of the global microbiology culture market in 2014, followed by other market segments such as synthetic media, special media and simple media. Demand for complex media is likely to witness continuous growth during the forecast period as it provides full range of growth factors required to cultivate unknown bacteria or bacteria with complex nutritional requirements. Additionally, demand for ready-to-use, off the shelf products in dehydrated and prepared culture media has increased significantly. This is expected to propel the segment in the near future.

Microbiology culture is the process of culturing microbiological organisms, wherein microorganisms are allowed to reproduce and multiply (grow in number) in a predetermined culture media and controlled laboratory conditions. Various culture methods with a vast range of culture media have been developed for the identification and characterization of microorganisms and are increasingly being used across the world. Presently, these microbiology cultures are used by microbiologists on a large scale in food, beverages, pharmaceuticals, research, cosmetics, and several other industries.

Key factors driving the global microbiology culture market are high demand for improved antibiotics, increasing food microbiology, rising life science research funding, and high prevalence of foodborne and other infectious diseases. 

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3232

Moreover, the microbiology culture market is witnessing strong growth due to rising food safety concerns, increasing number of food recalls, evolving pathogens, growing press coverage and public awareness, and increasing demand in other industries. Additionally, the industry is expected to expand at a rapid rate due to increased food sourcing due to rise in global food demand and supply. This, in turn, would require advanced culture methods and media for fast and accurate microbial analysis. Microbiology culture methods are the principal diagnostic methods used to determine the cause of infectious diseases by culturing the pathogen in a preset medium.

Read more: http://www.transparencymarketresearch.com/microbiology-culture-market.html

Population Health Management Solutions - How it works?

The terminology population health is defined as the outcome of health analyzed in a group of individuals. These groups are often geographic population such as communities or nations, but they also refer to groups such as disabled persons, ethnic groups, employer groups, prisoners and any other groups. This approach aims at improving the health of entire human population as health outcome of such groups is of relevance to policy makers in both public and private sectors. The landscape of healthcare industry is rapidly changing and patients clinical needs and delivery models have become complex. Thus, for providing better clinical care doctors, nurses, physicians, government bodies, employers and others are increasing adopting patient health management solutions across the globe. The introduction of patient health management solutions enable improved healthcare quality with reduced cost.

Aging population, technological advancements and improved demand for quality life and health are
the key factors that are anticipated to increase the market size of population health management solutions. Rising number of chronically ill patients and increasing focus on reduction of healthcare expenditure across the globe would also stimulate the demand for population health management solutions. However, lack of skilled labor especially in developing countries, huge investments and security of patient’s data are the key reasons that might impede the growth of this market.


Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4174

The population health management solutions market is highly fragmented hence intense competitive rivalry is witnessed among the players. Major players operating in this market are focusing on growth strategies such as mergers and acquisitions, agreements, collaborations, partnerships, innovations, marketing campaign and other promotional activities as to increase their market share. The prominent players operating in population health management solutions market includes. Cerner Corporation, Allscripts Healthcare Solutions, Inc., Explorys, Inc., Conifer Health Solutions, LLC, Healthagen, LLC. (A Subsidiary of Aetna, Inc.), Health Catalyst, LLC, Phytel, Inc., I2i Systems, Inc., Mckesson Corporation, Verisk Health, Inc., Wellcentive, Inc. and other major players. These players dominate the market due to innovative and highly effective products.

Rapidly Growing Geriatric Population to Boost Bone Morphogenetic Proteins Market Valuation to US$587.069 mn by 2022

Bone morphogenetic proteins (BMP) are naturally occurring proteins found in the human body. Identified in 1965 by Marshall Urist, bone morphogenetic proteins are among the most potent growth factors that induce mesenchymal stem cells to differentiate into osteoblast cells. Twenty different types of BMPs have been discovered to date; only BMP 2, 7 and 9 have osteoinductive property and have been proven to play a significant role in bone formation. However, of these, only BMP-2 and BMP-7 are commercially available. These proteins trigger intracellular signal pathways by binding to the receptor of the mesenchymal stem cells resulting in transformation of stem cells into tissue specific progenitor cells. These cells are involved in the synthesis of musculoskeletal tissue formation, extracellular growth and matrix.

The bone morphogenetic proteins market report studies the current scenario as well as future market potential for bone morphogenetic proteins globally. The market overview section of the report comprises qualitative analysis of the overall bone morphogenetic proteins market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces analysis and market attractiveness analysis. In addition, various analyses such as event regulatory scenario and value chain analysis have also been provided. Value chain analysis includes the study of major steps involved in the recombinant bone morphogenetic proteins preparation and distribution. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of recombinant bone morphogenetic proteins products.

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2308

Bone morphogenetic proteins (BMPs) that are classified under transforming growth factor beta superfamily are multifactorial growth factors. These are naturally occurring proteins found in the human body, involved in numerous cellular responses. BMPs were first isolated in 1965 by scientist Marshall Urist for the ability to induce the formation of bone and cartilage. To date over 15 BMPs have been isolated and cloned. However, only BMP-2 and BMP-7 are considered to show the greatest amount of osteoinductive potential. Both the types of BMPs share similar kind of cell receptors (Type 1 and Type 2 BMP receptor) that help in regulating bone growth. Thus, for clinical use, BMPs are produced through recombinant DNA technology namely rhBMP-2 and rhBMP-7. These BMPs have been approved by the FDA for use in orthopedic applications such as spinal fusions, oral surgery, and tibia non-unions. These proteins posses the ability to induce patients own cells for bone formation.

In addition, BMPs have proved to be beneficial for patients undergoing spinal fusion surgery by eliminating the need for bone harvesting from the pelvis region. This innovative research approach also reduces the amount of pain, dependence on spinal rods or screws, and augments the rate of spinal fusion. Although, BMPs have proved to be a noteworthy bone graft substitute in spinal fusion, a variety of complications are associated with its off-label usage. Uncontrolled bone formation, bone overgrowth, male sterility, leg pain, back pain, respiratory complication, and inflammation are some of the side effects associated with the implant of BMPs. Thus, the market for BMPs has been restricted by biocompatibility issues, high cost, strict regulations, and presence of numerous bone graft substitutes.

In terms of regional distribution, North America currently accounts for the largest share of the bone morphogenetic proteins market, followed by Europe. Furthermore, North America, with a market share of over 70%, is expected to dominate the industry during the forecast period. This leadership would be witnessed due to high awareness about BMP products, availability of premium priced recombinant BMP products, and soaring number of spinal fusion procedures. Furthermore, highest growth of this industry is expected to emerge in Asia Pacific during the forecast period. The global bone morphogenetic proteins market is characterized by three players namely Medtronic plc, Olympus Biotech, and Cellumed.

Know more: http://www.transparencymarketresearch.com/bone-morphogenetic-protein-market.html

Food Giant Nestlé Ventures Forth into Diagnostic Devices Industry with Alzheimer’s Detection Test

The medical devices industry is brimming with opportunities, enticing behemoths from the technology domain, such as Apple and Google, to venture into this territory. And now, an unlikely contender hopes to cash in on the lucrative opportunities that exist in the med devices industry. Food giant Nestlé is venturing forth with a diagnostic device that helps detect Alzheimer’s early on. The Nestle Institute of Health Sciences (NIHS) has developed a proprietary platform and is now moving to deploy it for the development of an assay to detect Alzheimer’s disease early on. According to recent estimates, over 44 mn people worldwide reportedly suffer from Alzheimer’s disease.

To this end, the NIHS inked an agreement with AC Immune SA, a France-based biopharmaceutical company, to develop a test that would identify tangles of Tau proteins. Based on previous research, scientists at Nestle say that Tau proteins are among the two most prominent symptoms of neurodegeneration.

Thus, by developing a diagnostic device that can spot this important causative factor, Nestle expects to break into a space that has not been commercially exploited thus far in the Alzheimer’s diagnosis field. Beta-amyloid plaques are the other important hallmark of neurodegeneration. Nestle’s strategy is to use the Tau proteins as a biomarker to aid the detection and diagnosis of Alzheimer’s.

Ed Baetge, who heads the NIHS, said that its latest deal with AC Immune will open up several new growth avenues through which it hopes to grab a share in the expanding revenue pie of the medical devices industry. He described the next-generation Nestle platform as being “ultrasensitive.” The test will be minimally invasive and will use blood samples from patients to detect the disease. Tau said that proprietary diagnostic technology was acquired along with its acquisition of Prometheus Laboratories in 2011. The NIHS says that it has been using the technology in its various brain research programs since the last two years.

Exploring the Growing Use of Personal Mobility Devices and the Reasons Behind It

Personal mobility devices include medical devices that assist in mobility and help in improving the overall quality of life of the physically disabled and/or geriatric individuals. Devices such as wheelchairs, mobility scooters, canes, crutches, walkers, and rollators are among the major personal mobility devices that are increasingly being demanded in the global market. Promoting mobility equipment and associated devices would facilitate reduction in public health expenditure as the sheer number of geriatric or disabled individuals and their associated needs are posing challenge to the domestic infrastructure, particularly the health systems. Another striking feature of this epidemiological transition is that the geriatric population in developing countries is estimated to exceed by 250%, which is far higher than the projected 71% increase in developed countries based on the findings of the WHO study on global AGEing and Adult Health (SAGE). Therefore, there will be significant growth in this market in the future.

Furthermore, due to the entry of various government and private geriatric/senior citizens, the health insurance players and other international organizations operating for assistance of disabled and elderly population would also facilitate growth of this market. The insurance players would help in reducing the cost of these devices to its end-users by covering various assistive devices under reimbursement plans, and thereby help in making them more affordable to the consumers. This is likely to increase demand for these devices in various price sensitive regions of the world.

The medical mobility aids & ambulatory devices segment comprises six sub-segments: wheelchairs, scooters, canes & crutches, walkers, stair lifts, and others. The medical furniture & bathroom safety products segment is further categorized into patient lifts, medical beds, bars & railings, commodes & shower chairs, and others. The market for these segments and sub-segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Medical beds and wheelchairs were observed as the largest and fastest growing product markets. The major factors driving the personal mobility devices market are high prevalence and increasing incidences of several chronic diseases, their longevity, and increasing disability rates along with increased government funding.

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6715


The key players operating in the global personal mobility devices market are Amigo Mobility International, Inc., Argo Medical, ArjoHuntleigh, Drive Medical, Graham-Field Health Products Incorporated, Hill-Rom Holdings, Inc., Invacare Corporation, Otto Bock Healthcare GmbH, Patterson Medical Holdings, Inc., Permobil AB, Pride Mobility Products Corporation, Stryker Corporation, and Sunrise Medical LLC. In terms of revenue, it was observed that Invacare Corporation held the largest share followed by Hill-Rom Holdings, Inc. in global personal mobility devices market in 2014. The key market players are actively involved in constant innovations and developments related to technology and application to cater the multi-dimensional needs of the end-users for maintaining their position in the global market.

Know more: http://www.transparencymarketresearch.com/personal-mobility-devices-market.html

Prevention is Getting Easier with Veterinary Antiseptics

Hydrogen peroxide as an antiseptic is commonly used for the treatment and removal of pus and debris from the wound due to its harsh characteristics. Hydrogen peroxide is also used for cleaning fish ponds, animal water reservoirs, and cages. Alcohol, due to its rapid evaporation action, is less preferred over chlorhexidine and iodine and iodophors based antiseptics. Moreover, several studies have illustrated that alcohol induces bacterial regrowth in wounds. The other products segment includes silver compounds and acetic acid. Silver compounds are used as mild antiseptics and in ophthalmic preparations. Silver nitrate, commonly used as a caustic antiseptic and an astringent, is mostly used in cats and dogs. The degree of action for silver nitrate depends upon the concentration used and the duration for which the compound is allowed to act. Acetic acid is majorly used as wound dressing and in urinary tract irrigation.

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=6448

Chlorhexidine is widely known for its antiseptic activity in oral care. It is relatively non-irritating to tissues and is used as a bactericidal, virucidal, and fungicidal. Chlorhexidine has limited activity against fungi and mycobacterium. Chlorhexidine as an antiseptic is widely used among horses, cats, sheep, cows, poultry animals, and dogs for the treatment of superficial cuts, abrasions, and insect stings. The potential disadvantages of chlorhexidine include staining of pellicle, unpleasant taste, and desensitized taste buds. Therefore, it is the second leading product in emerging and developing markets. Hydrogen peroxide is a harsh antiseptic agent and can damage the healthy tissues around the wound or abrasion. Despite this characteristic, hydrogen peroxide is an excellent germicidal agent majorly used to remove pus and debris from the wound. Apart from the direct application of hydrogen peroxide on animals, it is used to clean cages, fish ponds, and animal fur.

In dogs, hydrogen peroxide is used to induce vomiting in case of toxic ingestion apart from the prevention of septic. The veterinary antiseptic industry is witnessing impressive growth due to rising demand for animal food products and increasing adoption of companion animals such as cat and dogs. Furthermore, changing lifestyle in developing countries such as China and India has resulted in an increased adoption of pet animals. This is driving the animal health care market in the region. The study of the veterinary antiseptic market in these regions offers a comprehensive understanding of various antiseptic products, injuries therapies, animal welfare laws, animal statistics, marketing and branding strategies, and other core factors of the market.

The study comprises a detailed analysis of the antiseptic products, and helps in understanding various drivers contributing to the market growth in real-time and in the near future. Furthermore, the study focuses on the best practices in animal care, the science behind antiseptic and healing wounds, and the currently prevalent standards of practice in the region. Moreover, the research includes an in-depth competitive analysis and a market model in terms of competitive strategy and current market share. The stakeholders of this report include manufacturers of antiseptic products, wound and injury care products, and companies involved in the distribution of various products such as spirit, alcohol and chlorhexidine and new entrants who wish to enter the market.

Know more: http://www.transparencymarketresearch.com/veterinary-antiseptics-market.html